Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment

Transplant Proc. 1998 Aug;30(5):2389-91. doi: 10.1016/s0041-1345(98)00664-2.
No abstract available

MeSH terms

  • Abatacept
  • Adult
  • Antigens, CD
  • Antigens, Differentiation / genetics
  • Antigens, Differentiation / physiology
  • CTLA-4 Antigen
  • Cells, Cultured
  • Cytokines / genetics
  • Cytokines / pharmacology
  • Cytokines / physiology*
  • Dexamethasone / pharmacology
  • Fas Ligand Protein
  • Gene Expression Regulation / drug effects
  • Graft Rejection / diagnosis
  • Graft Rejection / immunology*
  • Graft Rejection / therapy
  • Granzymes
  • Humans
  • Immunoconjugates*
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / pharmacology
  • Interleukin-15 / genetics
  • Interleukin-15 / pharmacology
  • Interleukin-15 / physiology
  • Interleukin-2 / pharmacology
  • Interleukin-2 / physiology
  • Interleukin-7 / pharmacology
  • Interleukin-7 / physiology
  • Kinetics
  • Lymphocyte Activation* / drug effects
  • Membrane Glycoproteins / genetics
  • Perforin
  • Polyenes / pharmacology*
  • Polymerase Chain Reaction
  • Pore Forming Cytotoxic Proteins
  • Recombinant Proteins / pharmacology
  • Reference Values
  • Serine Endopeptidases / genetics
  • Sirolimus
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • Transcription, Genetic / drug effects*

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Cytokines
  • FASLG protein, human
  • Fas Ligand Protein
  • Immunoconjugates
  • Immunosuppressive Agents
  • Interleukin-15
  • Interleukin-2
  • Interleukin-7
  • Membrane Glycoproteins
  • Polyenes
  • Pore Forming Cytotoxic Proteins
  • Recombinant Proteins
  • Perforin
  • Abatacept
  • Dexamethasone
  • GZMB protein, human
  • Granzymes
  • Serine Endopeptidases
  • Sirolimus